Figure 4: Urinary β2-microglobulin (β2-MG) concentrations of diabetic patients showing nephrotic syndrome due to diabetic glomerulosclerosis (DGS) and minimal change nephrotic syndrome (MCNS). *p <0.01 versus DGS group by Kruskal–Wallis test. Data are mean ± SEM.